Emerging families of biomarkers for coronary artery disease: inflammatory mediators

References

• MorrowDASabatineMSBrennanMLConcurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18Eur Heart J20082991096110218339606
   PubMed Web of Science ®Google Scholar
• NageshCMRoyARole of biomarkers in risk stratification of acute coronary syndromeIndian J Med Res201013262763321150016
   PubMed Web of Science ®Google Scholar
• KumarACannonCPAcute coronary syndromes: diagnosis and management, part IMayo Clin Proc2009841091793819797781
   PubMed Web of Science ®Google Scholar
• JamesSKArmstrongPBarnathanEGUSTO-IV-ACS InvestigatorsTroponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudyJ Am Coll Cardiol200341691692412651034
   PubMed Web of Science ®Google Scholar
• MorrowDAde LemosJASabatineMSAntmanEMThe search for a biomarker of cardiac ischemiaClin Chem200349453753912651803
   PubMed Web of Science ®Google Scholar
• PearsonTAMensahGAAlexanderRACenters for Disease Control and PreventionAmerican Heart AssociationMarkers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart AssociationCirculation2003107349951112551878
   PubMed Web of Science ®Google Scholar
• VasanRSBiomarkers of cardiovascular disease: molecular basis and practical considerationsCirculation2006113192335236216702488
   PubMed Web of Science ®Google Scholar
• AppleFSWuAHMairJet al; Committee on Standardization of Markers of Cardiac Damage of theIFCCFuture biomarkers for detection of ischemia and risk stratification in acute coronary syndromeClin Chem200551581082415774573
   PubMed Web of Science ®Google Scholar
• MorrowDABraunwaldEFuture of biomarkers in acute coronary syndromes: moving toward a multimarker strategyCirculation2003108325025212876133
   PubMed Web of Science ®Google Scholar
• FusterVBadimonLBadimonJJChesebroJHThe pathogenesis of coronary artery disease and the acute coronary syndromesN Engl J Med199232642422501727977
   PubMed Web of Science ®Google Scholar
• RossRAtherosclerosis – an inflammatory diseaseN Engl J Med199934021151269887164
   PubMed Web of Science ®Google Scholar
• HarrisTBFerrucciLTracyRPAssociation of elevated interleukin-6 and C-reactive protein levels with mortality in elderlyAm J Med1999106550651210335721
   PubMed Web of Science ®Google Scholar
• BeckBCWeintraubWSAlexanderRWElevation of C-reactive protein in “active” coronary artery diseaseAm J Cardiol19906531681722296885
   PubMed Web of Science ®Google Scholar
• de BeerFCHindCRFoxKMAllanRMMaseriAPepysMBMeasurement of serum C-reactive protein concentration in myocardial ischemia and infarctionBr Heart J19824732392437059401
   PubMedGoogle Scholar
• LiuzzoGBiasucciLMGallimoreJRThe prognostic value of C-reactive protein and serum amyloid A protein in severe unstable anginaN Engl J Med199433174174247880233
   PubMed Web of Science ®Google Scholar
• RidkerPMHennekensCHBuringJERifaiNC-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenN Engl J Med20003421283684310733371
   PubMed Web of Science ®Google Scholar
• RidkerPMRifaiNClearfieldMAir Force/Texas Coronary Atherosclerosis Prevention Study InvestigatorsMeasurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary eventsN Engl J Med2001344261959196511430324
   PubMed Web of Science ®Google Scholar
• RidkerPMGlynnRJHennekensCHC-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarctionCirculation19989720200720119610529
   PubMed Web of Science ®Google Scholar
• ChewDPBhattDLRobbinsMAIncremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary interventionCirculation2001104999299711524391
   PubMed Web of Science ®Google Scholar
• HeeschenCHammCWBruemmerJSimoonsMLPredictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 Anti-platelet Therapy in Unstable angina Refractory to standard treatment trialJ Am Coll Cardiol20003561535154210807457
   PubMed Web of Science ®Google Scholar
• LindahlBTossHSiegbahnAVengePWallentinLMarkers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery DiseaseN Engl J Med2000343161139114711036119
   PubMed Web of Science ®Google Scholar
• BiasucciLMLiuzzoGGrilloRLElevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instabilityCirculation199999785586010027805
   PubMed Web of Science ®Google Scholar
• de WinterRJBholasinghRLijmerJGIndependent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarctionCardiovasc Res199942124024510435016
   PubMed Web of Science ®Google Scholar
• KullerLHTracyRPShatenJMeilahnENRelation of C-reactive protein and coronary artery disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention TrialAm J Epidemiol199614465375478797513
   PubMed Web of Science ®Google Scholar
• NohHJKwonNHJooSBSeverity of coronary atherosclerosis; influence of metabolic syndrome risk factor clustering and hs-CRPKorean Circ J20063612802808
   Google Scholar
• DooYCParkWJParkSHThe optimal timing to measure C-reactive protein to predict cardiac events in patients with unstable anginaKorean Circ J2001313290296
   Google Scholar
• KimTIChaeSCYangDHShort-term prognostic value of CRP in the patients with acute coronary syndromeKorean Circ J2000301113871394
   Google Scholar
• HaverkateFThompsonSGPykeSDGallimoreJRPepysMBProduction of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study GroupLancet199734990504624669040576
   PubMed Web of Science ®Google Scholar
• RossiEBiasucciLMCitterioFRisk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive proteinCirculation2002105780080311854118
   PubMed Web of Science ®Google Scholar
• RolphMSZimmerSBottazziBGarlandaCMantovaniAHanssonGKProduction of the long pentraxin PTX3 in advanced atherosclerotic plaquesArterioscler Thromb Vasc Biol2002225e10e1412006411
   PubMed Web of Science ®Google Scholar
• GarlandaCBottazziBBastoneAMantovaniAPentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertilityAnnu Rev Immunol20052333736615771574
   PubMed Web of Science ®Google Scholar
• PeriGIntronaMCorradiDPTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humansCirculation2000102663664110931803
   PubMed Web of Science ®Google Scholar
• LatiniRMaggioniAPPeriGLipid Assessment Trial Italian Network (LATIN) InvestigatorsPrognostic significance of the long pentraxin PTX3 in acute myocardial infarctionCirculation2004110162349235415477419
   PubMed Web of Science ®Google Scholar
• DubinRLiYIxJHShlipakMGWhooleyMPeraltaCAAssociations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary artery disease: data from the Heart and Soul StudyAm Heart J2012163227427922305847
   PubMed Web of Science ®Google Scholar
• JennyNSArnoldAMKullerLHTracyRPPsatyBMAssociations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health StudyArterioscler Thromb Vasc Biol200929559459919164811
   PubMedGoogle Scholar
• LeeDHJeonHKYouJHPentraxin 3 as a novel marker predicting congestive heart failure in subjects with acute coronary syndromeKorean Circ J201040837037620830250
   PubMedGoogle Scholar
• AlamNKhanHIChowdhuryAWElevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarctionBangladesh Med Res Counc Bull201238191322545344
   PubMedGoogle Scholar
• WashioTNomotoKWatanabeITaniSNagaoKHirayamaARelationship between plasma homocysteine levels and congestive heart failure in patients with acute myocardial infarction. Homocysteine and congestive heart failureInt Heart J201152422422821828948
   PubMed Web of Science ®Google Scholar
• Agoşton-ColdeaLMocanTSeiceanAGatfosséMRosenstinglSThe plasma homocysteine concentrations and prior myocardial infarctionRom J Intern Med2010481657221180243
   PubMedGoogle Scholar
• KosugeMEbinaTIshikawaTSerum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromesCirc J200771218619017251664
   PubMed Web of Science ®Google Scholar
• KatayamaTNakashimaHTakagiCPrognostic value of serum amyloid A protein in patients with acute myocardial infarctionCirc J200569101186119116195614
   PubMed Web of Science ®Google Scholar
• JohnsonBDKipKEMarroquinOCNational Heart, Lung, and Blood InstituteSerum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)Circulation2004109672673214970107
   PubMed Web of Science ®Google Scholar
• TousoulisDPapageorgiouNAndroulakisEBriasoulisAAntoniadesCStefanadisCFibrinogen and cardiovascular disease: genetics and biomarkersBlood Rev201125623924521652129
   PubMed Web of Science ®Google Scholar
• ReinhartWHFibrinogen – marker or mediator of vascular disease?Vasc Med20038321121614989564
   PubMed Web of Science ®Google Scholar
• CoppolaGRizzoMAbrignaniMGFibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up studyItal Heart J20056431532215902930
   PubMedGoogle Scholar
• YayanJErythrocyte sedimentation rate as a marker for coronary heart diseaseVasc Health Risk Manag2012821922322536077
   PubMedGoogle Scholar
• ErikssenGLiestølKBjørnholtJVStormorkenHThaulowEErikssenJErythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortalityEur Heart J200021191614162010988014
   PubMed Web of Science ®Google Scholar
• TimmerJROttervangerJPHoorntjeJCZwolle Myocardial Infarction study groupPrognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemiaJ Intern Med2005257542342915836658
   PubMed Web of Science ®Google Scholar
• van der LaanAMHirschARobbersLFA proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarctionAm Heart J201216315765 e222172437
   PubMed Web of Science ®Google Scholar
• TousoulisDAndroulakisEPapageorgiouNFrom atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligandTrends Cardiovasc Med201020515316421742271
   PubMed Web of Science ®Google Scholar
• SetiantoBYHartopoABAchadionoDNGhariniPPAssociation between levels of circulating soluble CD40 ligand on admission and in-hospital events among acute coronary syndrome patientsActa Med Indones2011432828721785169
   PubMedGoogle Scholar
• JefferisBJWhincupPHWelshPProspective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and womenJ Thromb Haemost2011981452145921696538
   PubMed Web of Science ®Google Scholar
• AbramsonNMeltonBLeukocytosis: basics of clinical assessmentAm Fam Physician20006292053206011087187
   PubMed Web of Science ®Google Scholar
• GrauAJBoddyAWDukovicDACAPRIE InvestigatorsLeukocyte count as an independent predictor of recurrent ischemic eventsStroke20043551147115215017013
   PubMed Web of Science ®Google Scholar
• AkhtarNAdilMMAhmedWHabib-ur-RehmanShahsMAThe role of leukocyte counts in patients with unstable angina pectoris or myocardial infarction; prognostic significance and correlation with plasma brain natriuretic peptide (BNP) levelsJ Pak Med Assoc2011611515422368903
   PubMed Web of Science ®Google Scholar
• BjörkbackaHLavantEHFredriksonGNWeak associations between human leucocyte antigen genotype and acute myocardial infarctionJ Intern Med20102681505820141563
   PubMed Web of Science ®Google Scholar
• MeissnerJIrfanATwerenboldRUse of neutrophil count in early diagnosis and risk stratification of AMIAm J Med2011124653454221507368
   PubMed Web of Science ®Google Scholar
• MaugeriNRovere-QueriniPEvangelistaVAn intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromesPLoS ONE201276e3948422761804
   PubMed Web of Science ®Google Scholar
• MurasakiSMurasakiKTanoueKKawanaMHagiwaraNKasanukiHCirculating platelet and neutrophil activation correlates with the clinical course of unstable anginaHeart Vessels200722637638218043994
   PubMed Web of Science ®Google Scholar
• SchaubNReichlinTMeuneCMarkers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarctionClin Chem201258124625622057876
   PubMed Web of Science ®Google Scholar
• BaldusSHeeschenCMeinertzTCAPTURE InvestigatorsMyeloperoxidase serum levels predict risk in patients with acute coronary syndromesCirculation2003108121440144512952835
   PubMed Web of Science ®Google Scholar
• BrennanMLPennMSVan LenteFPrognostic value of myeloperoxidase in patients with chest painN Engl J Med2003349171595160414573731
   PubMed Web of Science ®Google Scholar
• StankovicSAsaninMMajkic-SinghNThe usefulness of myeloperoxidase in prediction of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary interventionClin Lab2012581–212513122372355
   PubMed Web of Science ®Google Scholar
• MorrowDAWangYCroceKMyeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trialAm Heart J20081551495518082488
   PubMed Web of Science ®Google Scholar
• BonacaMPSciricaBMSabatineMSProspective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromesJ Am Coll Cardiol201260433233822813612
   PubMed Web of Science ®Google Scholar
• IversenKKDalsgaardMTeisnerASPregnancy-associated plasma protein-A, a marker for outcome in patients suspected for acute coronary syndromeClin Biochem20104310–1185185720388505
   PubMed Web of Science ®Google Scholar
• KhanDASharifMSKhanFADiagnostic performance of high-sensitivity troponin T, myeloperoxidase, and pregnancy-associated plasma protein A assays for triage of patients with acute myocardial infarctionKorean J Lab Med201131317217821779191
   PubMedGoogle Scholar
• KobayashiNHataNKumeNSoluble lectin-like oxidized low-density lipoprotein receptor-1 as an early biomarker for ST elevation myocardial infarction: time-dependent comparison with other biomarkers: time-dependent comparison with other biomarkersCirc J20117561433143921467660
   PubMed Web of Science ®Google Scholar
• HayashidaKKumeNMuraseTSerum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosisCirculation2005112681281816061745
   PubMed Web of Science ®Google Scholar
• DohiTMiyauchiKOkazakiSDecreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndromeAtherosclerosis2011219290791222024276
   PubMed Web of Science ®Google Scholar
• GargPKMcClellandRLJennyNSAssociation of lipoprotein-associated phospholipase A(2) and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA)Vasc Med201116424725221708876
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative GroupLipoprotein-associated phospholipase A2 activity and mass in relation to vascular disease and nonvascular mortalityJ Intern Med2010268434835821050287
   PubMed Web of Science ®Google Scholar
• MallatZLambeauGTedguiALipoprotein-associated and secreted phospholipases A2 in cardiovascular disease: roles as biological effectors and biomarkersCirculation2010122212183220021098459
   PubMed Web of Science ®Google Scholar
• GonçalvesIEdsfeldtAKoNYEvidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammationArterioscler Thromb Vasc Biol20123261505151222499993
   PubMed Web of Science ®Google Scholar
• FalconeCLucibelloSMazzucchelliIGalectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndromeInt J Immunopathol Pharmacol201124490591322230397
   PubMed Web of Science ®Google Scholar
• López-MejíasRGarcía-BermúdezMGonzález-JuanateyCLack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritisTissue Antigens201178643844121981268
   PubMedGoogle Scholar
• van DiepenSRoeMTLopesRDBaseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trialJ Thromb Thrombolysis201234110611322307842
   PubMed Web of Science ®Google Scholar
• FanZXHuaQLiYPLiuRKYangZInterleukin-6, but not soluble adhesion molecules, predicts a subsequent mortality from cardiovascular disease in patients with acute ST-segment elevation myocardial infarctionCell Biochem Biophys201161244344821594636
   PubMed Web of Science ®Google Scholar
• CavusogluEMarmurJDHojjatiMRPlasma interleukin-10 levels and adverse outcomes in acute coronary syndromeAm J Med2011124872473021787901
   PubMed Web of Science ®Google Scholar
• WelshPMurrayHMFordIPROSPER Study GroupCirculating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at riskArterioscler Thromb Vasc Biol201131102338234421757655
   PubMed Web of Science ®Google Scholar
• JafarzadehAEsmaeeli-NadimiANoughHNematiMRezayatiMTSerum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart diseaseAnadolu Kardiyol Derg200992758319357047
   PubMedGoogle Scholar
• JafarzadehANematiMRezayatiMTSerum levels of interleukin (IL)-27 in patients with ischemic heart diseaseCytokine201156215315621795063
   PubMed Web of Science ®Google Scholar
• DhillonOSNarayanHKQuinnPASquireIBDaviesJENgLLInterleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNPAm Heart J201116161163117021641364
   PubMed Web of Science ®Google Scholar
• KunesPHolubcovaZKolackovaMKrejsekJInterleukin-33, a novel member of the IL-1/IL-18 cytokine family, in cardiology and cardiac surgeryThorac Cardiovasc Surg201058844344921113894
   PubMed Web of Science ®Google Scholar
• SuchanekHMyśliwskaJSiebertJHigh serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitusEur Cytokine Netw200516317718516266856
   PubMed Web of Science ®Google Scholar
• PattiGMegaSPasceriVInterleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarctionClin Cardiol200528419319615869054
   PubMed Web of Science ®Google Scholar
• DevauxYBousquenaudMRodiusSTransforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarctionBMC Med Genomics201148322136666
   PubMed Web of Science ®Google Scholar
• OemrawsinghRMLenderinkTAkkerhuisKMCAPTURE investigatorsMultimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndromeHeart201197131061106621558475
   PubMed Web of Science ®Google Scholar
• Dizdarević-HudićLKusljugićZBarakovićFCorrelation between interleukin 6 and interleukin 10 in acute myocardial infarctionBosn J Basic Med Sci20099430130620001996
   PubMedGoogle Scholar
• MälarstigAErikssonPHamstenALindahlBWallentinLSiegbahnARaised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndromeHeart200894672472917690160
   PubMed Web of Science ®Google Scholar
• PaakkanenRLokkiMLSeppänenMTieralaINieminenMSSinisaloJProinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarctionAtherosclerosis2012221246146622310063
   PubMed Web of Science ®Google Scholar
• ChangLTYuenCMSunCKRole of stromal cell-derived factor-1alpha, level and value of circulating interleukin-10 and endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplastyCirc J20097361097110419372622
   PubMed Web of Science ®Google Scholar
• EitelIBlasePAdamsVGrowth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonanceHeart201197863264021345844
   PubMed Web of Science ®Google Scholar
• SchaubNReichlinTTwerenboldRGrowth differentiation factor-15 in the early diagnosis and risk stratification of patients with acute chest painClin Chem201258244144922205695
   PubMed Web of Science ®Google Scholar
• HarutyunyanMJMathiasenABWinkelPCLARICOR Trial GroupHigh-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trialScand J Clin Lab Invest2011711526221108561
   PubMed Web of Science ®Google Scholar
• PembertonCJSiriwardenaMKleffmannTFirst identification of circulating prepro-A-type natriuretic peptide (preproANP) signal peptide fragments in humans: initial assessment as cardiovascular biomarkersClin Chem201258475776722291141
   PubMed Web of Science ®Google Scholar
• BertonGCordianoRPalmieriRCavutoFButtazziPPalatiniPComparison of C-reactive protein and albumin excretion as prognostic markers for 10-year mortality after myocardial infarctionClin Cardiol201033850851520734449
   PubMed Web of Science ®Google Scholar
• KimJSHwangHJKoYGIschemia-modified albumin: is it a reliable diagnostic and prognostic marker for myocardial ischemia in real clinical practice?Cardiology2010116212312920588021
   PubMed Web of Science ®Google Scholar
• WudkowskaAGochJGochAIschemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectorisKardiol Pol201068443143720425705
   PubMed Web of Science ®Google Scholar
• KavsakPAHillSABhanich SupapolWDevereauxPJWorsterABiomarkers for predicting serious cardiac outcomes at 72 hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromesClin Chem201258129830221933901
   PubMed Web of Science ®Google Scholar
• HaasBSerchiTWagnerDRProteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarkerJ Proteomics201175122923621767674
   PubMed Web of Science ®Google Scholar
• CharpentierSDucasséJLCournotMClinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency departmentAcad Emerg Med2010171273520078436
   PubMed Web of Science ®Google Scholar
• BaliLCuissetTGiorgiRPrognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromesArch Cardiovasc Dis20081011064565119056071
   PubMed Web of Science ®Google Scholar
• HolmJRavnJIngemann HansenSUrinary excretion of alpha1-microglobulin and albumin in acute myocardial infarction. Correlation with plasma concentrations of troponin I and C-reactive proteinScand J Urol Nephrol200640433934416916777
   PubMed Web of Science ®Google Scholar
• AtaoğluHEYilmazFUzunhasanIProcalcitonin: a novel cardiac marker with prognostic value in acute coronary syndromeJ Int Med Res2010381526120233513
   PubMed Web of Science ®Google Scholar
• BektasFSoyuncuSGunduzIBasariciIAkbasHEkenCThe value of procalcitonin, a novel inflammatory marker, in the diagnosis of myocardial infarction and evaluation of acute coronary syndrome patientsJ Emerg Med201141552453020813483
   PubMed Web of Science ®Google Scholar
• KellyDKhanSQDhillonOProcalcitonin as a prognostic marker in patients with acute myocardial infarctionBiomarkers201015432533120214413
   PubMed Web of Science ®Google Scholar
• KafkasNVenetsanouKPatsilinakosSProcalcitonin in acute myocardial infarctionAcute Card Care2008101303617924232
   PubMedGoogle Scholar
• SchiopuAHedbladBEngströmGStruckJMorgenthalerNGMelanderOPlasma procalcitonin and the risk of cardiovascular events and death: a prospective population-based studyJ Intern Med2012272548449122530956
   PubMed Web of Science ®Google Scholar
• TanKLuSChenYCXC chemokine ligand 16 as a prognostic marker in patients with intermediate coronary artery lesions: a 2-year follow-up studyTohoku J Exp Med2011223427728321467783
   PubMed Web of Science ®Google Scholar
• NgLLKhanSQNarayanHQuinnPSquireIBDaviesJEProteinase 3 and prognosis of patients with acute myocardial infarctionClin Sci2011120623123820942801
   PubMed Web of Science ®Google Scholar
• PalikheASinisaloJSeppänenMSerum complement C3/C4 ratio, a novel marker for recurrent cardiovascular eventsAm J Cardiol200799789089517398178
   PubMed Web of Science ®Google Scholar
• WitkowskaAMSoluble ICAM-1: a marker of vascular inflammation and lifestyleCytokine200531212713415919214
   PubMed Web of Science ®Google Scholar